The Regents of the University of Colorado, a body corporate;IM Therapeutics
发明人:
Gottlieb, Peter A.,Michels, Aaron,Orndorff, Steve
申请号：
AU2017236977
公开号：
AU2017236977A1
申请日:
2017.03.22
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
Methods of treating, ameliorating, or inhibiting the development of autoimmune diseases by modulating the binding of MHC class II molecules to antigenic peptides or fragments of antigenic peptides of the autoimmune disease. The binding may be modulated by the administration of D-α-methyldopa, or pharmaceutical compositions comprising therapeutically effective amounts of D-α-methyldopa.
